Clinical Trials Logo

Clinical Trial Summary

Colonic diverticula are common in Western countries, affecting up to 60% of subjects over 70 years of age. In about 80% of patients, colonic diverticula remain asymptomatic (diverticulosis), while approximately 20% of patients may develop abdominal symptoms (symptomatic uncomplicated diverticular disease, SUDD) and, eventually, complications such as bouts of diverticulitis or bleeding.

A small proportion of patients with colonic diverticulosis may develop segmental colitis associated with diverticulosis (SCAD). SCAD is separate clinical disease with specific macroscopic (erythema, friability and ulcerations) and microscopic features characterized by chronic, mucosal inflammation involving the inter-diverticular mucosa (usually sigmoid colon) sparing the proximal colon and rectum colon.

The most common symptoms of SCAD are rectal bleeding, diarrhoea and abdominal pain.

To achieve SCAD diagnosis a correct biopsies sampling is mandatory. It is necessary to take biopsies on the borders of the diverticula and in the apparently normal adjacent mucosa as well as biopsies in both the colon proximal to the diverticular area and the rectum in order to exclude chronic inflammatory bowel disease. The spectrum of histological lesions associated with SCAD is variable, including mild non-specific inflammation and inflammatory bowel disease (IBD)-like changes.

Currently, data regarding prevalence of SCAD are scarce. It has been estimated that in patients with diverticulosis, SCAD prevalence ranged from 0.3-1.3%.

The aim of the present study is to assess prospectively the prevalence of segmental colitis associated with colon diverticulosis (SCAD), in consecutive patients with colic diverticulosis, in a tertiary university centre.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04279821
Study type Observational
Source University of Roma La Sapienza
Contact Bruno Annibale, MD
Phone 0633775695
Email bruno.annibale@uniroma1.it
Status Recruiting
Phase
Start date February 1, 2020
Completion date March 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT03602677 - Indocyanine Green Fluorescence Imaging in Prevention of Colorectal Anastomotic Leakage N/A
Completed NCT00535652 - Concentration of Ertapenem in Colorectal Tissue Phase 4
Not yet recruiting NCT03465293 - Influence of Mechanical Bowel Preparation on GI Microbiota N/A
Completed NCT03619538 - Interest of the Nefopam and PCA Morphine Combination for Postoperative Analgesia in Patients Undergoing Colon Surgery N/A
Completed NCT05106101 - L-glutamine Treatment in Patients With Diverticulosis Phase 1
Recruiting NCT02752360 - Biodegradable Stenting Anastomoses Versus Double-layer Hand Sutures for Reconstruction in Intestinal Anastomosis Phase 1
Completed NCT00663247 - Mechanistic Randomized Controlled Trial (RCT) of Mesalazine in Symptomatic Diverticular Disease N/A
Completed NCT05384925 - Prior Abdominal Surgery: A Potential Risk Factor for Colonic Diverticulosis or Diverticulitis